生命科学仪器2026，Vol.24Issue(2)：140-142,3.DOI:10.11967/2026240444
乌司他丁辅助治疗老年重症肺炎的最新应用进展
The Latest Application Progress of Ulinastatin in The Adjuvant Treatment of Severe Pneumonia in The Elderly
李慧婷 1李军2
作者信息
- 1. 承德医学院,河北 承德 067000
- 2. 承德医学院附属医院全科医疗科,河北 承德 067000
- 折叠
摘要
Abstract
Severe pneumonia is a common serious infectious disease with high morbidity and mortality in the elder-ly.Because the elderly have the characteristics of decreased autoimmune function,many basic diseases and poor or-gan function reserve,it is difficult to treat and the prognosis is poor.Ulinastatin is a polypeptide drug extracted from human urine,which has a wide range of biological activities and significant functions in anti-inflammatory,anti-oxidation and organ protection.The adjuvant use of ulinastatin in the treatment of elderly patients with se-vere pneumonia can not only improve the clinical symptoms of patients quickly,but also shorten the treatment time and improve the effectiveness and safety of treatment.This paper reviews the latest application progress of ulinas-tatin in the adjuvant treatment of severe pneumonia in the elderly.关键词
乌司他丁/老年重症肺炎/药理机制/应用进展Key words
Ulinastatin/Severe pneumonia in the elderly/Pharmacological mechanism/Application progress分类
医药卫生引用本文复制引用
李慧婷,李军..乌司他丁辅助治疗老年重症肺炎的最新应用进展[J].生命科学仪器,2026,24(2):140-142,3.
